172 related articles for article (PubMed ID: 20554195)
1. Rare genetic variants and the risk of cancer.
Bodmer W; Tomlinson I
Curr Opin Genet Dev; 2010 Jun; 20(3):262-7. PubMed ID: 20554195
[TBL] [Abstract][Full Text] [Related]
2. General lessons from large-scale studies to identify human cancer predisposition genes.
Cazier JB; Tomlinson I
J Pathol; 2010 Jan; 220(2):255-62. PubMed ID: 19927315
[TBL] [Abstract][Full Text] [Related]
3. Common polymorphisms in checkpoint kinase 2 are not associated with breast cancer risk.
Kuschel B; Auranen A; Gregory CS; Day NE; Easton DF; Ponder BA; Dunning AM; Pharoah PD
Cancer Epidemiol Biomarkers Prev; 2003 Aug; 12(8):809-12. PubMed ID: 12917215
[TBL] [Abstract][Full Text] [Related]
4. The search for low-penetrance cancer susceptibility alleles.
Houlston RS; Peto J
Oncogene; 2004 Aug; 23(38):6471-6. PubMed ID: 15322517
[TBL] [Abstract][Full Text] [Related]
5. Effect of ATM, CHEK2 and ERBB2 TAGSNPs and haplotypes on endometrial cancer risk.
Einarsdóttir K; Humphreys K; Bonnard C; Li Y; Li Y; Chia KS; Liu ET; Hall P; Liu J; Wedrén S
Hum Mol Genet; 2007 Jan; 16(2):154-64. PubMed ID: 17164260
[TBL] [Abstract][Full Text] [Related]
6. Discovering moderate-risk breast cancer susceptibility genes.
Hollestelle A; Wasielewski M; Martens JW; Schutte M
Curr Opin Genet Dev; 2010 Jun; 20(3):268-76. PubMed ID: 20346647
[TBL] [Abstract][Full Text] [Related]
7. No increased susceptibility to breast cancer from combined CHEK2 1100delC genotype and the HLA class III region risk factors.
de Jong MM; Nolte IM; Te Meerman GJ; van der Graaf WT; Oosterom E; Bruinenberg M; Steege Gv; Oosterwijk JC; van der Hout AH; Boezen HM; Schaapveld M; Kleibeuker JH; de Vries EG
Eur J Cancer; 2005 Aug; 41(12):1819-23. PubMed ID: 16043347
[TBL] [Abstract][Full Text] [Related]
8. How many genes underlie the occurrence of common complex diseases in the population?
Yang Q; Khoury MJ; Friedman J; Little J; Flanders WD
Int J Epidemiol; 2005 Oct; 34(5):1129-37. PubMed ID: 16043441
[TBL] [Abstract][Full Text] [Related]
9. Constraints for genetic association studies imposed by attributable fraction and familial risk.
Hemminki K; Bermejo JL
Carcinogenesis; 2007 Mar; 28(3):648-56. PubMed ID: 17012223
[TBL] [Abstract][Full Text] [Related]
10. Mutation analysis and characterization of ATR sequence variants in breast cancer cases from high-risk French Canadian breast/ovarian cancer families.
Durocher F; Labrie Y; Soucy P; Sinilnikova O; Labuda D; Bessette P; Chiquette J; Laframboise R; Lépine J; Lespérance B; Ouellette G; Pichette R; Plante M; Tavtigian SV; Simard J
BMC Cancer; 2006 Sep; 6():230. PubMed ID: 17010193
[TBL] [Abstract][Full Text] [Related]
11. The associations of sequence variants in DNA-repair and cell-cycle genes with cancer risk: genotype-phenotype correlations.
Hall J; Marcel V; Bolin C; Fernet M; Tartier L; Vaslin L; Hainaut P
Biochem Soc Trans; 2009 Jun; 37(Pt 3):527-33. PubMed ID: 19442246
[TBL] [Abstract][Full Text] [Related]
12. Mutation analysis of BRIP1 in male breast cancer cases: a population-based study in Central Italy.
Silvestri V; Rizzolo P; Falchetti M; Zanna I; Masala G; Bianchi S; Palli D; Ottini L
Breast Cancer Res Treat; 2011 Apr; 126(2):539-43. PubMed ID: 21165771
[TBL] [Abstract][Full Text] [Related]
13. Common genetic variation at PTEN and risk of sporadic breast and prostate cancer.
Haiman CA; Stram DO; Cheng I; Giorgi EE; Pooler L; Penney K; Le Marchand L; Henderson BE; Freedman ML
Cancer Epidemiol Biomarkers Prev; 2006 May; 15(5):1021-5. PubMed ID: 16702386
[TBL] [Abstract][Full Text] [Related]
14. Sequence variants in Toll-like receptor gene cluster (TLR6-TLR1-TLR10) and prostate cancer risk.
Sun J; Wiklund F; Zheng SL; Chang B; Bälter K; Li L; Johansson JE; Li G; Adami HO; Liu W; Tolin A; Turner AR; Meyers DA; Isaacs WB; Xu J; Grönberg H
J Natl Cancer Inst; 2005 Apr; 97(7):525-32. PubMed ID: 15812078
[TBL] [Abstract][Full Text] [Related]
15. Association of rare MSH6 variants with familial breast cancer.
Wasielewski M; Riaz M; Vermeulen J; van den Ouweland A; Labrijn-Marks I; Olmer R; van der Spaa L; Klijn JG; Meijers-Heijboer H; Dooijes D; Schutte M
Breast Cancer Res Treat; 2010 Sep; 123(2):315-20. PubMed ID: 19924528
[TBL] [Abstract][Full Text] [Related]
16. ATM variants and cancer risk in breast cancer patients from Southern Finland.
Tommiska J; Jansen L; Kilpivaara O; Edvardsen H; Kristensen V; Tamminen A; Aittomäki K; Blomqvist C; Børresen-Dale AL; Nevanlinna H
BMC Cancer; 2006 Aug; 6():209. PubMed ID: 16914028
[TBL] [Abstract][Full Text] [Related]
17. Genetic association studies of complex traits: design and analysis issues.
Newton-Cheh C; Hirschhorn JN
Mutat Res; 2005 Jun; 573(1-2):54-69. PubMed ID: 15829237
[TBL] [Abstract][Full Text] [Related]
18. CHEK2 1100delC is a susceptibility allele for HNPCC-related colorectal cancer.
Wasielewski M; Vasen H; Wijnen J; Hooning M; Dooijes D; Tops C; Klijn JG; Meijers-Heijboer H; Schutte M
Clin Cancer Res; 2008 Aug; 14(15):4989-94. PubMed ID: 18676774
[TBL] [Abstract][Full Text] [Related]
19. Chromosome 8q24 risk variants in hereditary and non-hereditary prostate cancer patients.
Sun J; Lange EM; Isaacs SD; Liu W; Wiley KE; Lange L; Gronberg H; Duggan D; Carpten JD; Walsh PC; Xu J; Chang BL; Isaacs WB; Zheng SL
Prostate; 2008 Apr; 68(5):489-97. PubMed ID: 18213635
[TBL] [Abstract][Full Text] [Related]
20. Genome-wide association studies of cancer predisposition.
Stadler ZK; Vijai J; Thom P; Kirchhoff T; Hansen NA; Kauff ND; Robson M; Offit K
Hematol Oncol Clin North Am; 2010 Oct; 24(5):973-96. PubMed ID: 20816582
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
